English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 6 August 2015, 12:32 HKT/SGT
Nobel Prize Winner for Economics, Dr. Myron Scholes Bought Shares of C.banner
Focusing on Chinese High-quality Retailer, Optimistic about the Company's Future Development

HONG KONG, Aug 6, 2015 - (ACN Newswire) - C.banner International Holdings Limited ("C.banner" or the "Company", together with its subsidiaries, the "Group", stock code: 1028), the second largest retailer of middle-to-high-end women's formal and leisure footwear in the PRC, has bought back its stock shares from market frequently in July, reflecting that the management has sufficient confidence in the Company's future and is devoted to maintain the interest for shareholders. It has learned that the famous American economist, Nobel Prize Winner for Economics, Dr. Myron Scholes bought Company stock recently, indicating his confidence in the value and future development of the Company. He also expressed his intention to increase shareholding of C.banner in the future.

Dr. Myron Scholes is a famous Canadian-American economist. He earned his Ph.D. at the University of Chicago and was a professor at MIT, University of Chicago and currently is an Emeritus Professor at Stanford University. As co-originator of the Black-Scholes options pricing model, he was awarded the Nobel Memorial Prize in Economic Sciences in 1997 with Prof. Robert C. Merton of Harvard University for their great contribution in developing the technology to value derivatives and hailed as the "Father of Current Derivatives Theory".

Dr. Myron Scholes conducts research on the implications of the shift in the Chinese economy from an infrastructure to more of a consumer basis for the growth of the economy. He visits China from time to time. He expressed confidence in the Company's financial condition and its future business prospects, which lead to his initial investment and his intended further open-market purchase of C.banner's shares.

Mr. Chen Yixi, Chairman of C.banner said, "The Company feels honored to attract attention and investment of a famous American economist. C.banner actively adjusts its strategies to meet changing conditions in a complicated and challenging economic environment. We expect a long-term investment interest from Dr. Myron Scholes. The Company will further enhance its strength and profitability to maximize the value for each investor."

Topic: Press release summary
Sectors: Daily Finance
From the Asia Corporate News Network

Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

View Image

Latest Press Releases
HKTDC unveils plans to drive new business opportunities for Hong Kong  
Feb 22, 2019 21:00 HKT/SGT
Asia World Sees Myanmar's New Concrete Road as Catalyst and Confidence Booster for Investments Into Rakhine  
Feb 22, 2019 19:00 HKT/SGT
NEC Develops 5G Base Station Equipment Compliant with O-RAN Fronthaul Specifications  
Feb 22, 2019 13:55 HKT/SGT
Mobile industry leaders to Develop O-RAN Fronthaul-Compliant Products and Drive Multi-vendor Radio Access Networks  
Feb 22, 2019 13:29 HKT/SGT
Mitsubishi Shipbuilding Holds Christening Ceremony for Next-Generation LNG Carrier "MARVEL CRANE"  
Feb 22, 2019 12:43 HKT/SGT
Mitsubishi Motors Lineup at 89th Geneva Motor Show  
Feb 22, 2019 08:37 HKT/SGT
Champion REIT Announces 2018 Annual Results  
Feb 21, 2019 19:27 HKT/SGT
ZEN (SET:ZEN) Undergoes First Trading Day, Confident in Strong Fundamentals  
Feb 21, 2019 17:00 HKT/SGT
WARC forecasts global advertising spend to grow 4.3% to $616bn in 2019 but Internet adspend set to decrease 7.2% excluding Google/Facebook duopoly  
Feb 21, 2019 16:00 HKT/SGT
AbbVie and Eisai Announce Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA is the First in Japan to be Approved for the Treatment of Hidradenitis Suppurativa  
Feb 21, 2019 13:50 HKT/SGT
More Press release >>
More events >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8400